Jonathan David Schwartz - Insider Trading & Ownership

Location
430 East 29 Th Street, Suite 1040, New York, NY
Summary
The estimated net worth of Jonathan David Schwartz is at least $2.69M dollars as of November 20, 2025. Jonathan David Schwartz is the Chief Science & Gene Therapy Officer of ROCKET PHARMACEUTICALS, INC. and owns shares of ROCKET PHARMACEUTICALS, INC. (RCKT) stock worth about $2.69M.
Signature
/s/ Martin Wilson, as attorney-in-fact for Jonathan David Schwartz
All Insider Reports
All Insider Reports

Ownership of Jonathan David Schwartz

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RCKT, RCKTW ROCKET PHARMACEUTICALS, INC. Chief Science & Gene Therapy Officer $2.69M -$174K -6.07% Nov 18, 2025
TRHC Tabula Rasa HealthCare, Inc. Director Nov 3, 2023

Insider Transactions Reported by Jonathan David Schwartz:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.